ThromboGenics Appoints Dominique Vanfleteren as New CFO
News Jan 17, 2015
ThromboGenics NV has announced the appointment of Dominique Vanfleteren as its new Chief Financial Officer (CFO) with immediate effect.
Dominique Vanfleteren has over 25 years of experience in senior finance, operational, control and reporting roles within quoted international biopharmaceutical companies.
Before joining ThromboGenics, Dominique spent 12 years at UCB, a global biopharmaceutical company, where he held a number of international managerial finance positions, the latest being the CFO of UCB’s Asia Pacific Operations, operating from Brussels and Shanghai.
Prior to joining UCB, Dominique worked for GSK during 16 years. He held a number of senior finance positions in Brussels and London, his latest being Finance Director of GSK’s Diversified Healthcare Services Europe.
Dr Patrik De Haes, Chief Executive Officer of Thrombogenics, said: “I am delighted to welcome Dominique Vanfleteren to Thrombogenics as our new CFO. Dominique is bringing significant financial experience from within the biopharmaceutical industry and I am confident that he will prove a great addition to our senior management team as we look to execute our strategy as announced in mid-2014.”
Commenting on his appointment, Dominique Vanfleteren said: “I am very pleased to be joining ThromboGenics and excited to be able to contribute to the Company’s future success based on the further development of JETREA®, as well as on its broader strategy of developing innovative medicines for the treatment of ophthalmic diseases focused on diabetic retinopathy.”
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE
Lab Innovations returns to the NEC, Bimingham , UKNews
Save the date for the UK’s only lab-dedicated exhibition showcase!READ MORE
Comments | 0 ADD COMMENT
International Conference on Biobetters and Regulatory Affairs
Jun 27 - Jun 28, 2018